FDA - Roster of the Tobacco Products Scientific Advisory Committee..

March 1, 2010 - As required by the Family Smoking Prevention and Tobacco Control Act (“Tobacco Act”), FDA has established the Tobacco Products Scientific Advisory Committee (“TPSAC”).

Present Roster of the Tobacco Products Scientific Advisory Committee..

March 30-31: Agenda for Meeting of the FDA Tobacco Products Scientific Advisory Committee..

Establishment of the TPSAC is critical to FDA’s timely implementation of the Tobacco Act because the TPSAC may (and in some cases must) be involved in a wide range of regulatory activities, including actions on premarket approvals, approvals of modified risk tobacco products, establishment of tobacco product standards, and establishment of good manufacturing practice requirements. In particular, “immediately upon the establishment of” the TPSAC, FDA must refer to it the politically and emotionally charged “issue of the impact of the use of menthol in cigarettes on the public health, including such use among children, African-Americans, Hispanics, and other racial and ethnic minorities.” FDCA Sec. 907(e). The TPSAC’s report and recommendations on this issue are due back to FDA within one year. The TPSAC must also consider the impact of dissolvable tobacco products on the public health, including their use by children, and report back to FDA within two years.

Reference: FDA Establishes Tobacco Products Scientific Advisory Committee and Requests Nominations for Members by David B. Clissold & Ricardo Carvajal, FDA Law Blog, 8/26/2009.